Post Profile






Cancer immunotherapy may get a boost by disabling specific T cells

(Columbia University Medical Center) Cancer immunotherapy drugs only work for a minority of patients, but a generic drug now used to increase blood flow may be able to improve those odds, a study by Columbia University Medical Center researchers suggests.
read more

share
See more about: Medical Center

Related Posts


Immunotherapy drug effective for metastatic triple negative breast cancer

Health : EurekAlert: Health

(NYU Langone Medical Center / New York University School of Medicine) The immunotherapy drug, Pembrolizumab, is effective in shrinking tumors among metastatic triple negative breast cancer patients as found in a clinical trial led b...

UNMC study to test 'breakthrough' drug in mantle cell lymphoma patients - FDA expected to approve drug in 6 months

Health : Medical News Today

The University of Nebraska Medical Center is involved in testing a drug the Food and Drug Administration has fast-tracked towards approval because of its dramatic results in patients with mantle cell lymphoma and other cancers. "Thi...

Leukemia drug combo is encouraging in early Phase I clinical trial

Health : EurekAlert: Health

(Columbia University Medical Center) In a Phase I study, 8 out of 12 patients with relapsed and/or chemotherapy refractory blood cancers responded to a combination of the chemotherapy drugs thioguanine and decitabine; some of the re...

Cancer Drug May Improve Memory In Alzheimer's Patients

Health : Medical News Today

A drug now used to treat cancer may also be able to restore memory deficits in patients with Alzheimer's disease, according to a new study conducted by scientists at Columbia University Medical Center, which appeared in the Septembe...

Cancer Immunotherapy May Get a Boost by Disabling Specific T Cells

Health : Newswise Medical News

Cancer immunotherapy drugs only work for a minority of patients, but a generic drug now used to increase blood flow may be able to improve those odds, a study by Columbia University Medical Center (CUMC) researchers suggests.

Comments


Copyright © 2016 Regator, LLC